Home Page Lawsuits Filed Lawsuit: Taxotere Hair Loss Lawsuit Filed
Taxotere Hair Loss Lawsuit Filed
Were you looking for Taxotere Permanent Hair Loss lawsuits?
Santa Clara, CA: Sanofi-Aventis is facing a defective product lawsuit alleging its cancer drug Taxotere (Docetaxel) causes hair loss. Filed by Erma Spann, the lawsuit claims Sanofi withheld important information from patients about the potential long-term side effects of Taxotere.
Spann alleges she has experienced on-going and permanent hair loss after undergoing chemotherapy involving Taxotere following a right breast partial mastectomy in February 2005.
Taxotere Hair Loss Lawsuit
Spann further alleges that Sanofi-Aventis knew or should have known that, unlike other cancer drugs, Taxotere had a high risk of permanent baldness, known as alopecia. She asserts that rather than issuing warnings regarding the potential for hair loss Sanofi concealed the information, depriving her and other patients of the opportunity to decide whether the risk of permanent baldness was justified.
"Although women might accept the possibility of permanent baldness as a result of the use of Taxotere if no other product were available to treat their cancer, this was not the case,"Spann states in the complaint. "Before Defendants' wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere."
The lawsuit cites a study published in 2005, known as GEICAM 9805, that found nearly 10% of patients who took Taxotere suffered permanent hair loss. The manufacturers were aware of that study and of observations by a Denver-based oncologist in 2006, which found that more than 6% of his Taxotere patients suffered permanent hair loss.
"Despite Defendants' knowledge of the relevant findings from the GEICAM 9805 study, as well as reports from patients who had taken Taxotere and suffered from permanent disfiguring hair loss, Defendants failed to provide accurate information and proper warnings to physicians, healthcare providers, and patients in the United States, including Plaintiff, that patients who take Taxotere are at a significantly increased risk of suffering from permanent disfiguring hair loss,"the lawsuit states. "Instead, Defendants chose to withhold this information in the United States despite advising physicians, patients, and regulatory agencies in other countries, including the European Union and Canada, that Taxotere causes an increased risk of permanent disfiguring hair loss."
According to the lawsuit, Taxotere warnings continue to vaguely and misleadingly indicate that "hair generally grows back"after use of the drug.
Taxotere Hair Loss Legal HelpIf you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on
TAXOTERE HAIR LOSS LEGAL ARTICLES AND INTERVIEWS
Court Order Means Potential Taxotere Plaintiffs Should Act ASAP
October 11, 2017New Orleans, LA: On September 7, 2017, the judge overseeing the multidistrict Taxotere hair loss litigation (MDL) issued a pre-trial order that compels attorneys to submit information about all pending and anticipated Taxotere lawsuits. The goal is to bring as many plaintiffs as possible into any settlement reached [READ MORE]
Did Sanofi-Aventis Have a Duty to Warn Patients about Permanent Hair Loss?
September 12, 2017Santa Clara, CA: As the litigation shakes out, that question is at the heart of Taxotere hair loss suits now pending in federal courts in Louisiana and other jurisdictions. But whether Sanofi-Aventis had a duty to warn patients is more complicated than it might appear. It requires courts to define what responsibility pharmaceutical companies have to the patients who look to them for a cure [READ MORE]
Signs of Movement in the Taxotere Litigation Process
August 27, 2017Dallas, TX Allegations that hundreds of American women experienced permanent hair loss as a result of using the breast cancer treatment drug Taxotere (Docetaxel) are about to be tested in court in a bellwether trial slated for next fall [READ MORE]
MORE TAXOTERE HAIR LOSS LEGAL NEWS
READ MORE [ Consumer Fraud Settlements and Legal News ]
READ MORE [ Defective Products Settlements and Legal News ]
READ MORE [ Drugs/Medical Settlements and Legal News ]
ADD YOUR COMMENT ON THIS ISSUE